The comment period is now over. CSAT has formed a committee to review the comments and the regulations. A short meeting is planned for January 31, 2000. Two NAMA officers are on the committee Lisa Torres, Esq. and Joycelyn Woods.
Buprenorphrine Committee
A federal committee has been formed to review the guidelines for buprenorphrine prescribing. Joycelyn Woods will be the consumer representative on the committee. The first meeting is scheduled in February.
Patient’s Bill of Rights
NAMA has been asked to be a Steakholder in a group that will develop documents about Patient’s Rights.
New England NAMA is very close to making methadone a reality in Vermont and New Hampshire. Contact Alice Diorio as to how you can help in this last push.
Anthony Scro is a NAMA volunteer, founder of the NAMA affiliate Association for the Betterment of Addiction Treatment and Education (ABATE) and has been a methadone advocate for over 20 years. It goes on and on. It seems like it may never end. We’ve all heard the same questions. Suffered the same humiliation. “When are…
Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office Draft approved for distribution July 2001 THE FEDERATION OF STATE MEDICAL BOARDS OF THE UNITED STATES, INC. Introduction On October 17, 2000, “The Children’s Health Act of 2000” (HR 4365) was signed into federal law. Section 3502 of that Act sets forth the “Drug…
The dilution of methadone with water was initiated as a result of the first federal methadone regulations because it was believed that this policy would reduce the diversion of methadone. While initially this policy may have had an impact within a short time most prospective buyers learning that methadone was now diluted with water knew…
Join a List or Group or Subscribe to a Zine A list or discussion group is a forum where people with a common interest join and discuss ideas. Another type of forum is the message board where you post a message on a website and others can read it. It is the equivalent of an…
There are many misperceptions and misunderstanding about the federal regulations and particularly when it comes to issues regarding raising the dose over 100 mgs. Prior to the HIV epidemic in order to raise a patient’s dose it was required for the physician to contact the Food and Drug Administration (FDA) for permission. In the early…
Justice Department Finds that Indiana State Nursing Board Discriminates Against People with Opioid Use Disorder March 30, 2022 FOR IMMEDIATE RELEASE Friday, March 25, 2022 Indianapolis – Today, the Justice Department found that the Indiana State Board of Nursing (Nursing Board) violated the Americans with Disabilities Act (Ada) by prohibiting nurses who take medication to…
